期刊文献+

QT间期离散度(QTd)对心脏同步化治疗评估研究 被引量:2

Influence of cardiac resynchronization therapy on QTd
下载PDF
导出
摘要 目的:观察心脏再同步治疗(CRT)对心肌复极离散的影响。方法:选取68例接受CRT植入的心力衰竭患者,根据术后6个月左心室射血分数绝对值是否较基线水平升高绝对值是否较基线水平提高≥10%,分为反应组(n=34)和无反应组(n=34)。比较两组患者CRT植入后不同时期QRS间期、QT间期复极离散度指标变化情况。结果:反应组患者术后1年QRS间期和QTd间期较术前和术后<24 h均明显缩短,差异有统计学意义(P<0.05),而无反应组各时期上述指标差异均无统计学意义,差异有统计学意义(P>0.05);68例患者中,CRT术后有22例出现室性心律失常,QTd间期在室性心律失常组较非室性心律失常组明显延长,差异有统计学意义(P<0.05)。结论:QTd在对CRT治疗患者术后的有效性是很好的评价指标。 Objective To investigate the effects of cardiac resynchronization therapy(CRT) in patients with dispersion of re-polarization and ventricular arrhythmia. Method 68 patients with biventricular pacemaker were included in this study. According to weather absolute value of LVEF increased≥10% from baseline at 6 months after CRT implantation,the patients were divided into 2 groups: Response group(n = 34) and Non-response group(n = 34). Dispersion of re-polarization indexes as QRS duration,QT interval and the events of ventricular arrhythmia were compared between 2 groups at different time points after CRT. Results In Response group,compared with pre-operation,QRS duration and QTd interval were shorter at 1 year and within 24 h after CRT implantation,all P〈0. 05,while the above indexes were similar in Non-response group,all P〈0. 05. Among 68 patients,there were 22 with ventricular arrhythmias(AV) after CRT. QTd interval were significantly longer in AV patients than those in non-AV patients(P〈0. 05). Conclusion CRT ventricular reverse remodeling may reduce dispersion of re-polarization. The incidence of AV is correlated to the extension of QTd interval of cardiac resynchronization therapy(CRT)in patients.
作者 徐锋 马兰 XU Feng;MA Lan(Department of electrocardiography, the Second Affiliated Hospital of Medical University Of Anhui,Hefei 230607, Chin)
出处 《吉林医学》 CAS 2018年第5期852-854,共3页 Jilin Medical Journal
关键词 慢性心力衰竭 心脏再同步治疗 QT间期离散度 Chronic heart failure Cardiac resynchronization therapy Dispersion of QT interval
  • 相关文献

参考文献3

二级参考文献23

  • 1李安莹,谭茗月,赵水平.心力衰竭患者循环血中肿瘤坏死因子-α、白细胞介素-6、高敏C反应蛋白水平的变化以及阿托伐他汀的干预作用[J].中国循环杂志,2006,21(6):435-437. 被引量:10
  • 2叶任高 主编.内科学:第5版[M].北京:人民卫生出版社,2001.824.
  • 3Guidelines for cardiac pacing and cardiac resynchronization therapy:The Task Force for Cardiac Pacing and Cardiac ResynchronizationTherapy of the European Society of Cardiology.Developed inCollaboration with the European Heart Rhythm Association.Eur HeartJ,2007,28:2256-2295.
  • 4Abraham WT.Rationale and design of a randomized clinical trial to assessthe safety and efficacy of cardiac resynchronization therapy in patientswith advanced heart failure:the Multicenter InSync Randomized ClinicalEvaluation(MIRACLE).Card fail,2000,6:369-380.
  • 5Bozkurt B,Kribbs SB,Clubb FJ,et al.Pathophysiologically relevantconcentrations of tumor necrosis factor-alpha promote progressive leftventricular dysfunction and remodeling in rats.Circulation,1998,97:1382-1391.
  • 6Alonso-Martinez JL,Llorente-Diez B,Echegaray-Agara M,et al.C-reactive protein as a predictor of improvement and readmission inheart failure.Eur J Heart Fail,2002,4:331-336.
  • 7Berton G,Cordiano R,Palmieri R,et al.C-reactive protein in acutemyocardial infarction:association with heart failure.Am Heart J,2003,145:1094-1101.
  • 8Bristow MR, Saxon LA, BoehmerJ, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failurelJ], N EnglJ Med,2004,350(2l):2140-2150.
  • 9ClelandJG, Daubert IC, Erdmann E, et aI. The effect of cardiac resynchronization on morbidity and mortality in heart failure[J].N EnglJ Med,2005,352( 15 ):1539-1549.
  • 10Task Force Members,Kenneth D,Panos EV,et aI.201O focused update of ESC guidelines on device therapy in heart failure[J].Europace, 201O,12( II ):1526-1536.

共引文献1293

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部